โ Active Ingredient Overview Table:
| ๐ฌ Active Ingredient (Generic Name): | Varenicline Tartrate |
|---|---|
| ๐ Indication: | Smoking Cessation (Tobacco Dependence) |
| ๐บ๐ธ US Brand: | Chantix |
| ๐ญ Manufacturer: | Healing Pharma (Founded: 2010) |
| ๐ฆ Packaging: | 10 Tablets per Box |
| ๐งช Strength: | 1 mg |
| ๐ Delivery Time: | 6โ15 days |
๐ฟ What is Varenicline 1 mg (Varenismart)?
Varenismart 1 mg represents the maintenance dose of Varenicline Tartrate, a targeted partial agonist at ฮฑ4ฮฒ2 nicotinic acetylcholine receptors in the brain. After a careful titration period, patients transition to this 1 mg twice-daily regimen to sustain receptor occupancy, significantly reducing nicotine cravings and blocking the reinforcing effects of smoking.
Quitting tobacco is a major challenge, with withdrawal symptoms such as irritability, anxiety, and cognitive fog affecting up to 90% of quitters. Vareniclineโs dual action not only mitigates these withdrawal symptoms but also diminishes the pleasurable feedback loop triggered by nicotine. Clinical trials reveal that maintaining a 1 mg dose twice daily doubles the abstinence rates at 12 weeks compared to placebo, with prolonged abstinence extending benefits through 52 weeks in many users.
Moreover, real-world data suggest that combining Varenismart 1 mg with supportive behavioral interventions yields the highest long-term quit rates. Patients also report improved mood and concentration, demonstrating Vareniclineโs positive impact on both physiological dependence and psychological withdrawal.
๐งฌ Pharmacology & Mechanism of Action
| Attribute | Detail |
|---|---|
| Chemical Formula | C13H13N3O2โข2HCl |
| Molecular Weight | 261.7 g/mol (tartrate salt) |
| Bioavailability | ~90% |
| Metabolism | Minimal hepatic (renal excretion) |
| Half-Life | ~24 hours |
By partially activating and simultaneously blocking nicotinic receptors, Varenicline reduces withdrawal and prevents nicotineโs rewarding effects.
๐ก Indications & Dosing
| Phase | Dose & Administration |
|---|---|
| Maintenance (Weeks 2โ12) | 1 mg twice daily, after titration with 0.5 mg dose |
Begin 0.5 mg once daily on days 1โ3, then 0.5 mg twice daily on days 4โ7, transitioning to 1 mg twice daily on day 8. Continue for 11 more weeks for optimal results.
โ ๏ธ Warnings & Side Effects
Common:
- Nausea, vivid dreams
- Insomnia, headache
Serious:
- Neuropsychiatric events (mood changes, suicidal ideation)
- Cardiovascular events in at-risk populations
Encourage patients to monitor mood and report any behavioral changes. Use caution in those with cardiovascular disease and avoid alcohol which may exacerbate neuropsychiatric effects.
๐ฅ Storage Instructions
Store Varenismart 1 mg in its original carton at 20โ25ยฐC. Keep away from moisture and direct sunlight. Store out of reach of children.
๐ Availability & Purchasing
- USA: Prescription-only (Chantix); brand and generic available.
- UK & EU: Prescription required; varenicline generics.
- Australia: Prescription and TGA approval required.
International sourcing can lower costs; ensure you comply with local regulations and maintain a valid prescription.
๐ Related Smoking Cessation Therapies
- Varenismart 0.5 mg โ initial titration dose.
- Zyban (Bupropion SR) 150 mg โ non-nicotine adjunct.
- Nicotine Gum 4 mg โ oromucosal quitting aid.
๐ฅ Educational Video on Varenicline Maintenance Therapy
๐ฉโโ๏ธ Expert Insight: Dr. Sunita Rao, Addiction Specialist
โTransitioning to Varenicline 1 mg twice daily is critical for sustaining receptor engagement and maximizing quit rates. Combined with counseling, Varenismart significantly improves long-term abstinence.โ




